Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis

References

• Ankeny DP, Popovich PG. (2009). Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience, 158, 1112–21
   PubMed Web of Science ®Google Scholar
• Araujo DM, Cotman CW. (1993). Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: Potential involvement of glial-derived factors. Brain Res, 600, 49–55
   PubMed Web of Science ®Google Scholar
• Bacon KB, Harrison JK. (2000). Chemokines and their receptors in neurobiology: Perspectives in physiology and homeostasis. J Neuroimmunol, 104, 92–7
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Walz A, Kunkel SL. (1989). Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest, 84, 1045–9
   PubMed Web of Science ®Google Scholar
• Bartosik-Psujek H, Stelmasiak Z. (2005). The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease. Euro J Neurol: Off J Euro Fed Neurol Soc, 12, 49–54
   PubMed Web of Science ®Google Scholar
• Brat DJ, Bellail AC, Van Meir EG. (2005). The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol, 7, 122–33
   PubMed Web of Science ®Google Scholar
• Carlson T, Kroenke M, Rao P, et al. (2008). The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exper Med, 205, 811–23
   PubMed Web of Science ®Google Scholar
• Charo IF, Ransohoff RM. (2006). The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med, 354, 610–21
   PubMed Web of Science ®Google Scholar
• Danik M, Puma C, Quirion R, Williams S. (2003). Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, gamma-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: A single-cell reverse transcription-multiplex polymerase chain reaction study. J Neurosci Res, 74, 286–95
   PubMedGoogle Scholar
• Fancy SP, Chan JR, Baranzini SE, et al. (2011). Myelin regeneration: A recapitulation of development? Annu Rev Neurosci, 34, 21–43
   PubMed Web of Science ®Google Scholar
• Guerrero AR, Uchida K, Nakajima H, et al. (2012). Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflamm, 9, 40
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Yoda M, Yamada M, et al. (1996). Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. Exp Hematol, 24, 123–8
   PubMed Web of Science ®Google Scholar
• Horuk R, Martin AW, Wang Z, et al. (1997). Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol, 158, 2882–90
   PubMed Web of Science ®Google Scholar
• Hosking MP, Tirotta E, Ransohoff RM, Lane TE. (2010). CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PLoS One, 5, e11340
   PubMedGoogle Scholar
• Huber AR, Kunkel SL, Todd RF, 3rd, Weiss SJ. (1991). Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science, 254, 99–102
   PubMed Web of Science ®Google Scholar
• Ishizu T, Osoegawa M, Mei FJ, et al. (2005). Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain: J Neurol, 128, 988–1002
   Google Scholar
• Kamali-Sarvestani E, Nikseresht AR, Aliparasti MR, Vessal M. (2006). IL-8 (-251 A/T) and CXCR2 (+1208 C/T) gene polymorphisms and risk of Multiple Sclerosis in Iranian patients. Neurosci Lett, 404, 159–62
   PubMed Web of Science ®Google Scholar
• Kaplanski G, Farnarier C, Kaplanski S, et al. (1994). Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood, 84, 4242–8
   PubMed Web of Science ®Google Scholar
• Khan S, Cole N, Hume EB, et al. (2007). The role of CXC chemokine receptor 2 in Pseudomonas aeruginosa corneal infection. J Leukoc Biol, 81, 315–8
   PubMedGoogle Scholar
• Kleine TO, Zwerenz P, Graser C, Zofel P. (2003). Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8. Brain Res Bull, 61, 327–46
   PubMedGoogle Scholar
• Keegan BM, Noseworthy JH. (2002). Multiple sclerosis. Ann Rev Med, 53, 285–302
   PubMed Web of Science ®Google Scholar
• Kesselring J. (1997). [Prognosis in multiple sclerosis]. Schweiz Med Wochenschr, 127, 500–5
   PubMedGoogle Scholar
• Kurtzke JF. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444–52
   PubMed Web of Science ®Google Scholar
• Larsen CG, Anderson AO, Appella E, et al. (1989). The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science, 243, 1464–6
   PubMed Web of Science ®Google Scholar
• Limatola C, Ciotti MT, Mercanti D, et al. (2002). Signaling pathways activated by chemokine receptor CXCR2 and AMPA-type glutamate receptors and involvement in granule cells survival. J Neuroimmunol, 123, 9–17
   PubMedGoogle Scholar
• Limatola C, Ciotti MT, Mercanti D, et al. (2000). The chemokine growth-related gene product beta protects rat cerebellar granule cells from apoptotic cell death through alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Proc Natl Acad Sci USA, 97, 6197–201
   PubMedGoogle Scholar
• Liu L, Belkadi A, Darnall L, et al. (2010). CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: Relevance to multiple sclerosis. Nat Neurosci, 13, 319–26
   PubMed Web of Science ®Google Scholar
• Lund BT, Ashikian N, Ta HQ, et al. (2004). Increased CXCL8 (IL-8) expression in Multiple Sclerosis. J Neuroimmunol, 155, 161–71
   PubMed Web of Science ®Google Scholar
• Marro BS, Hosking MP, Lane TE. (2012). CXCR2 signaling and host defense following coronavirus-induced encephalomyelitis. Future Virol, 7, 349–59
   PubMedGoogle Scholar
• McDonald WI. (2000). Relapse, remission, and progression in multiple sclerosis. N Engl J Med, 343, 1486–7
   PubMed Web of Science ®Google Scholar
• McFarland HF, Frank JA, Albert PS, et al. (1992). Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol, 32, 758–66
   PubMed Web of Science ®Google Scholar
• Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. (2000). Multiple sclerosis. N Engl J Med, 343, 938–52
   PubMed Web of Science ®Google Scholar
• Odinak MM, Bisaga GN, Kalinina NM, et al. (2001). [Immunogenetic cytokine restriction in multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova/Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov [i] Vserossiiskoe obshchestvo psikhiatrov 101:39–44
   Google Scholar
• Omari KM, John GR, Sealfon SC, Raine CS. (2005). CXC chemokine receptors on human oligodendrocytes: Implications for multiple sclerosis. Brain, 128, 1003–15
   PubMedGoogle Scholar
• Padovani-Claudio DA, Liu L, Ransohoff RM, Miller RH. (2006). Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2. Glia, 54, 471–83
   PubMedGoogle Scholar
• Polman CH, Reingold SC, Banwell B, et al. (2011). Diagnostic criteria for multiple sclerosis: (2010) revisions to the McDonald criteria. Ann Neurol, 69, 292–302
   PubMed Web of Science ®Google Scholar
• Pouly S, Becher B, Blain M, Antel JP. (2000). Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol, 59, 280–6
   PubMedGoogle Scholar
• Reutershan J. (2006). CXCR2—The receptor to hit? Drug News Perspect, 19, 615–23
   PubMed Web of Science ®Google Scholar
• Rose JJ, Foley JF, Murphy PM, Venkatesan S. (2004). On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2. J Biol Chem, 279, 24372–86
   PubMedGoogle Scholar
• Saas P, Walker PR, Quiquerez AL, et al. (2002). A self-defence mechanism of astrocytes against Fas-mediated death involving interleukin-8 and CXCR2. Neuroreport, 13, 1921–4
   PubMedGoogle Scholar
• Semple BD, Kossmann T, Morganti-Kossmann MC. (2010). Role of chemokines in CNS health and pathology: A focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab, 30, 459–73
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Higuchi T, Yamashita T, Koike K. (1999). Chemokine production by human megakaryocytes derived from CD34-positive cord blood cells. Cytokine, 11, 424–34
   PubMedGoogle Scholar
• Tirotta E, Kirby LA, Hatch MN, Lane TE. (2012). IFN-gamma-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling. Stem Cell Res, 9, 208–17
   PubMedGoogle Scholar
• Trebst C, Ransohoff RM. (2001). Investigating chemokines and chemokine receptors in patients with multiple sclerosis: Opportunities and challenges. Arch Neurol, 58, 1975–80
   PubMedGoogle Scholar
• Tsai HH, Frost E, To V, et al. (2002). The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell, 110, 373–83
   PubMed Web of Science ®Google Scholar
• Virtanen JO, Jacobson S. (2012). Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets, 11, 528–44
   PubMed Web of Science ®Google Scholar
• Weiss N, Deboux C, Chaverot N, et al. (2010). IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells. J Neuroimmunol, 223, 131–4
   PubMed Web of Science ®Google Scholar
• Xia M, Qin S, McNamara M, et al. (1997). Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Amer J Pathol, 150, 1267–1274
   PubMedGoogle Scholar
• Zlotnik A, Yoshie O. (2000). Chemokines: A new classification system and their role in immunity. Immunity, 12, 121–7
   PubMed Web of Science ®Google Scholar